Dr. James Cail, D.O

NPI: 1669403085
Total Payments
$3,243
2024 Payments
$261.33
Companies
38
Transactions
200
Medicare Patients
14
Medicare Billing
$3,907

Payment Breakdown by Category

Food & Beverage$3,243 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,243 200 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $369.86 27 $0 (2024)
Otsuka America Pharmaceutical, Inc. $329.21 19 $0 (2024)
ABBVIE INC. $322.58 18 $0 (2024)
Amgen Inc. $315.74 24 $0 (2020)
Genentech USA, Inc. $179.90 6 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $174.78 10 $0 (2020)
Corcept Therapeutics $170.41 10 $0 (2019)
Novo Nordisk Inc $165.07 12 $0 (2020)
Allergan, Inc. $154.47 10 $0 (2020)
Merck Sharp & Dohme Corporation $79.02 5 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $261.33 14 Janssen Pharmaceuticals, Inc ($97.37)
2023 $396.80 22 AbbVie Inc. ($218.63)
2022 $325.98 24 Janssen Pharmaceuticals, Inc ($120.15)
2021 $113.42 7 Janssen Pharmaceuticals, Inc ($72.79)
2020 $1,048 58 Genentech USA, Inc. ($134.65)
2019 $822.08 56 Amgen Inc. ($180.15)
2018 $254.98 18 Corcept Therapeutics ($53.90)
2017 $20.17 1 Allergan Inc. ($20.17)

All Payment Transactions

200 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/12/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $13.82 General
Category: Neuroscience
10/16/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $17.64 General
10/15/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $20.19 General
Category: Neuroscience
08/22/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $15.84 General
Category: Neuroscience
08/17/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.20 General
Category: PSYCHIATRY
08/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.16 General
Category: NEUROSCIENCE
08/02/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $15.74 General
Category: TESTOSTERONE REPLACEMENT THERAPY
06/04/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $33.98 General
Category: Neuroscience
05/13/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.78 General
Category: NEUROSCIENCE
04/11/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $18.20 General
Category: PSYCHIATRY
02/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.53 General
Category: NEUROSCIENCE
02/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.52 General
Category: NEUROSCIENCE
01/25/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $13.54 General
Category: Neuroscience
01/05/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.19 General
Category: PSYCHIATRY
12/11/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.44 General
Category: NEUROSCIENCE
11/03/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.96 General
Category: RESPIRATORY
10/21/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $32.97 General
Category: NEUROSCIENCE
10/06/2023 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), REXULTI Food and Beverage In-kind items and services $17.56 General
Category: PSYCHIATRY
09/19/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.72 General
Category: NEUROSCIENCE
09/01/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.88 General
Category: RESPIRATORY
08/25/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $19.05 General
Category: Neuropsychiatry
08/23/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.97 General
Category: NEUROSCIENCE
08/07/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.27 General
Category: NEUROSCIENCE
06/07/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $1.98 General
Category: NEUROSCIENCE
05/23/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $17.17 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 14 51 $7,803 $3,907
Total Patients
14
Total Services
51
Medicare Billing
$3,907
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 14 51 $7,803 $3,907 50.1%

About Dr. James Cail, D.O

Dr. James Cail, D.O is a Family Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669403085.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Cail, D.O has received a total of $3,243 in payments from pharmaceutical and medical device companies, with $261.33 received in 2024. These payments were reported across 200 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,243).

As a Medicare-enrolled provider, Cail has provided services to 14 Medicare beneficiaries, totaling 51 services with total Medicare billing of $3,907. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Oklahoma City, OK
  • Active Since 07/05/2006
  • Last Updated 03/20/2014
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1669403085

Products in Payments

  • VRAYLAR (Drug) $430.11
  • INVEGA SUSTENNA (Drug) $345.64
  • Aimovig (Biological) $213.49
  • REXULTI (Drug) $198.07
  • Xofluza (Drug) $179.90
  • JARDIANCE (Drug) $174.78
  • Korlym (Drug) $170.41
  • ABILIFY MAINTENA (Drug) $113.58
  • EVENITY (Biological) $74.68
  • Ozempic (Drug) $73.00
  • FLECTOR (Drug) $59.84
  • LATUDA (Drug) $54.96
  • JANUVIA (Drug) $49.05
  • EMGALITY (Drug) $45.79
  • ARISTADA (Drug) $42.95
  • TRINTELLIX (Drug) $42.67
  • MAKO (Device) $41.40
  • Saxenda (Drug) $38.81
  • FARXIGA (Drug) $37.73
  • MYRBETRIQ (Drug) $36.95

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Oklahoma City